The Hemophilia and Thrombosis Treatment Center launched its own clotting factor homecare program, called "Total Hemophilia Care," in 2010. The program is available to all of our patients with hemophilia, von Willebrand Disease and other bleeding disorders. As a federally funded hemophilia center, our program is authorized and regulated by the
Health Resources and Service Administration (HRSA) and part of 340B/PHS legislation. HRSA is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. Our center is committed to this mandate.
Proceeds from our HRSA-certified clotting factor program ensure funding for maintenance and expansion of patient programs and comprehensive care support for patients with hemophilia and bleeding disorders. Joining our clotting factor program means investment in personal long-term care, health, and well-being.
Below are commonly asked questions about our new 340B/PHS homecare program, Total Hemophilia Care.
+ Expand All
For more information on how the 340B program improves health outcomes and reduces costs, please watch this video,
340B and Hemophilia Treatment Centers: Improving Health Outcomes and Reducing Costs, produced by the US HTC Regions VIII, IX, and X.